St. Jude Medical (NYSE:STJ) is one of the relatively few large-cap medical technology companies managing to deliver ongoing growth through this tough part of the cycle. Unfortunately for shareholders, there is a great deal of uncertainty about whether St. Jude is going to continue to deliver enough growth to make the stock appealing for the long-haul.

IN PICTURES: 9 Simple Investing Ratios You Need To Know

The Quarter That Was
St. Jude reported total revenue growth of 7% for the third quarter, with the company's large CRM (cardiac rhythm management) business growing at 7%, and the smaller atrial fibrillation and neuromodulation businesses growing 8% and 11% respectively. Relative to "same-store" results from Boston Scientific (NYSE:BSX) and off-calendar comparisons to Medtronic (NYSE:MDT), St. Jude is almost certainly capturing shares in the large and lucrative (but slow-growing) CRM market. That is a good thing, as that is 60% of the company's business.

It seems as though every company has "one time" charges every quarter these days, so assessing St. Jude's profitability is subject to that disclaimer. Still, it appears that gross margin fell by about 150 basis points from last year, while operating income rose just under 10%. Those are not bad numbers per se, but the lower gross margin is a reason for pause. (For more, see Money To Be Made In Medical Devices.)

The Road Ahead
St. Jude has done well with past acquisitions (like Radi, Endocardial Solutions and Advanced Neuromodulation), and that should give investors some confidence that the recent deal for AGA Medical (Nasdaq:AGAM) will pay off in time. The question, though, is whether that will be enough. True, AGAM has four potential $1 billion product opportunities (which would almost double St. Jude's current revenue base), but the odds of going four-for-four are long (especially for AGAM's migraine application).

Longer term, the company needs to drive both revenue growth and higher cash flow efficiency. The company has benefited in the past from lower tax rates and so on, but those are not necessarily repeatable. That places an ongoing burden on the company to improve operating efficiency just to hold the line on its free cash flow conversion. (For related reading, check out 5 Stocks With Solid Cash Flow.)

The Bottom Line
St. Jude is unlikely to take a big swing and buy a company like Edwards Lifesciences (NYSE:EW), though a deal for a company like ZOLL (Nasdaq:ZOLL), Abiomed (Nasdaq: ABMD) or Thoratec (Nasdaq:THOR) could be viable. On its own, though, St. Jude will have its work cut out achieving the free cash flow growth it needs.

As it stands, St. Jude is probably slightly undervalued at today's price. Adding just 1% to the 10-year free cash flow growth rate would boost that target by about 6%, so that is the scale of the leverage that St. Jude faces. At today's prices, there are more interesting healthcare ideas, but St. Jude is at least holding its own in tough times. (For more, see Investing In The Healthcare Sector.)

Use the Investopedia Stock Simulator to trade the stocks mentioned in this stock analysis, risk free!

Related Articles
  1. Fundamental Analysis

    5 Must-Have Metrics For Value Investors

    Focusing on certain fundamental metrics is the best way for value investors to cash in gains. Here are the most important metrics to know.
  2. Stock Analysis

    Analyzing Altria's Return on Equity (ROE) (MO)

    Learn about Altria Group's return on equity (ROE) and analyze net profit margin, asset turnover and financial leverage to determine what is causing its high ROE.
  3. Investing News

    Icahn's Bet on Cheniere Energy: Should You Follow?

    Investing legend Carl Icahn continues to lose money on Cheniere Energy, but he's increasing his stake. Should you follow his lead?
  4. Stock Analysis

    Analyzing Google's Return on Equity (ROE) (GOOGL)

    Learn about Alphabet's return on equity. How has its ROE changed over time, how does it compare to its peers and what factors are driving ROE for the company?
  5. Investing News

    Is Buffett's Bet on Oil Right for You? (XOM, PSX)

    Oil stocks are getting trounced, but Warren Buffett still likes one of them. Should you follow the leader?
  6. Stock Analysis

    The Top 5 Micro Cap Alternative Energy Stocks for 2016 (AMSC, SLTD)

    Follow a cautious approach when purchasing micro-cap stocks in the alternative energy sector. Learn about five alternative energy micro-caps worth considering.
  7. Stock Analysis

    Analyzing Porter's Five Forces on Under Armour (UA)

    Learn about Under Armour and how it differentiates itself in the competitive athletic apparel industry in light of the Porter's Five Forces Model.
  8. Stock Analysis

    The Biggest Risks of Investing in Qualcomm Stock (QCOM, BRCM)

    Understand the long-term fundamental risks related to investing in Qualcomm stock, and how financial ratios also play into the investment consideration.
  9. Stock Analysis

    The Biggest Risks of Investing in Johnson & Johnson Stock (JNJ)

    Learn the largest risks to investing in Johnson & Johnson through fundamental analysis and other potential risks. Also discover how JNJ compares to its peers.
  10. Investing News

    Chipotle Served with Criminal Probe

    Chipotle's beat muted expectations and got a clear bill from the CDC, but it now appears that an investigation into its E.coli breakout has expanded.
  1. What is the formula for calculating EBITDA?

    When analyzing financial fitness, corporate accountants and investors alike closely examine a company's financial statements ... Read Full Answer >>
  2. How do I calculate the P/E ratio of a company?

    The price-earnings ratio (P/E ratio) is a valuation measure that compares the level of stock prices to the level of corporate ... Read Full Answer >>
  3. How do you calculate return on equity (ROE)?

    Return on equity (ROE) is a ratio that provides investors insight into how efficiently a company (or more specifically, its ... Read Full Answer >>
  4. How do you calculate working capital?

    Working capital represents the difference between a firm’s current assets and current liabilities. The challenge can be determining ... Read Full Answer >>
  5. What is the formula for calculating the current ratio?

    The current ratio is a financial ratio that investors and analysts use to examine the liquidity of a company and its ability ... Read Full Answer >>
  6. What is the formula for calculating earnings per share (EPS)?

    Earnings per share (EPS) is the portion of a company’s profit that is allocated to each outstanding share of common stock, ... Read Full Answer >>
Trading Center